These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 1959381
21. Pharmacokinetics and delta1-cortienic acid excretion after intravenous administration of prednisolone and loteprednol etabonate in rats. Wu WM, Tang Y, Buchwald P, Bodor N. Pharmazie; 2010 Jun; 65(6):412-6. PubMed ID: 20614688 [Abstract] [Full Text] [Related]
22. Attenuation of ocular hypertension with the use of topical loteprednol etabonate 0.5% in steroid responders after corneal transplantation. Holland EJ, Djalilian AR, Sanderson JP. Cornea; 2009 Dec; 28(10):1139-43. PubMed ID: 19770719 [Abstract] [Full Text] [Related]
23. Comparison of human ocular distribution of bimatoprost and latanoprost. Ichhpujani P, Katz LJ, Hollo G, Shields CL, Shields JA, Marr B, Eagle R, Alvim H, Wizov SS, Acheampong A, Chen J, Wheeler LA. J Ocul Pharmacol Ther; 2012 Apr; 28(2):134-45. PubMed ID: 22136089 [Abstract] [Full Text] [Related]
24. Improved ocular: systemic absorption ratio of timolol by viscous vehicle and phenylephrine. Kyyrönen K, Urtti A. Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1827-33. PubMed ID: 2211028 [Abstract] [Full Text] [Related]
26. Intraocular penetration of topical clindamycin in rabbits. Mercer KB, DeOlden JE, Leopoid IH. Arch Ophthalmol; 1978 May; 96(5):880-4. PubMed ID: 655926 [Abstract] [Full Text] [Related]
27. Soft drugs--10. Blanching activity and receptor binding affinity of a new type of glucocorticoid: loteprednol etabonate. Druzgala P, Hochhaus G, Bodor N. J Steroid Biochem Mol Biol; 1991 Feb; 38(2):149-54. PubMed ID: 2004037 [Abstract] [Full Text] [Related]
28. Pharmacokinetics of topical ocular phenylephrine HCl. Antoine ME, Edelhauser HF, O'Brien WJ. Invest Ophthalmol Vis Sci; 1984 Jan; 25(1):48-54. PubMed ID: 6698730 [Abstract] [Full Text] [Related]
29. Comparison of concentration-time profiles of levobunolol and timolol in anterior and posterior ocular tissues of albino rabbits. Acheampong AA, Breau A, Shackleton M, Luo W, Lam S, Tang-Liu DD. J Ocul Pharmacol Ther; 1995 Jan; 11(4):489-502. PubMed ID: 8574812 [Abstract] [Full Text] [Related]
30. Loteprednol etabonate ophthalmic suspension 0.5 %: efficacy and safety for postoperative anti-inflammatory use. Amon M, Busin M. Int Ophthalmol; 2012 Oct; 32(5):507-17. PubMed ID: 22707339 [Abstract] [Full Text] [Related]
34. Metabolites of isopropyl unoprostone as potential ophthalmic solutions to reduce intraocular pressure in pigmented rabbits. Kashiwagi K, Iizuka Y, Tsukahara S. Jpn J Pharmacol; 1999 Sep; 81(1):56-62. PubMed ID: 10580371 [Abstract] [Full Text] [Related]
35. Development of simultaneous quantification method of loteprednol etabonate (LE) and its acidic metabolites, and analysis of LE metabolism in rat. Samir A, Kage A, Ohura K, Imai T. Xenobiotica; 2019 May; 49(5):569-576. PubMed ID: 29781759 [Abstract] [Full Text] [Related]